info@seagull-health.com
SeagullHealth
语言:
search
new
How to Use ExtraSuperTadarise
504
Article source: Seagull Pharmacy
Sep 19, 2025

ExtraSuperTadarise is a combination preparation containing two active ingredients, Tadalafil and Dapoxetine. It is used for the treatment of male erectile dysfunction (ED) and premature ejaculation (PE).

How to Use ExtraSuperTadarise

Routine Dosage and Administration

Recommended Dosage: The usual dosage is 1 tablet taken orally once daily. The dosage may be adjusted based on individual response. The common specification is 20mg Tadalafil + 60mg Dapoxetine.

Dosage Form and Specification: It is a film-coated tablet, which should be swallowed whole and must not be broken or chewed.

Administration Requirements: It is recommended to take the tablet 30-60 minutes before sexual activity, and it can be taken with or without food.

Pre-Treatment Evaluation

Cardiovascular Evaluation: It is necessary to ensure that there is no risk of severe heart disease or hypotension.

Drug Interaction Check: Concomitant use with nitrates or potent CYP3A4 inhibitors should be avoided.

Precautions for Medication Use

Need for Sexual Stimulation: Sexual stimulation is required to trigger the drug's effect.

Dietary Impact: High-fat diets may delay the absorption of Dapoxetine but do not affect the efficacy of Tadalafil.

Precautions for Using ExtraSuperTadarise

Contraindications

Nitrates: Concomitant use with any form of nitrates is strictly prohibited, as it may lead to severe hypotension.

Severe Cardiovascular Diseases: Such as recent myocardial infarction, unstable angina pectoris, etc.

Adverse Reactions Requiring Vigilance

Cardiovascular Events: Symptoms such as chest pain and palpitations require immediate medical attention.

Neurological Symptoms: Dapoxetine may cause dizziness or syncope; avoid driving or operating machinery.

Patients with Hepatic Impairment

Mild to Moderate Hepatic Impairment: No dosage adjustment is needed, but close monitoring is required.

Severe Hepatic Impairment: Use should be avoided due to insufficient data.

Patients with Renal Impairment

Moderate Renal Impairment: The maximum dosage should not exceed 10mg Tadalafil, and the medication should be administered at intervals of 48 hours.

Severe Renal Impairment or Dialysis Patients: Use is contraindicated.

Elderly Patients (≥65 Years Old)

Caution is required. The initial dosage is recommended to be halved, and blood pressure and heart rate should be monitored.

Patients on Concomitant Medications

For CYP3A4 Inhibitors (such as Ketoconazole, Ritonavir), the dosage of Tadalafil should be limited to 10mg, and only one dose should be taken within 72 hours.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Recommended Articles
Indications of ExtraSuperTadarise
ExtraSuperTadarise is a combined preparation mainly used for the treatment of male erectile dysfunction (ED) and premature ejaculation (PE). As an enhanced formulation of Tadalafil, it combines the me...
What Are the Side Effects of Etrasimod?
Etrasimod is a sphingosine-1-phosphate (S1P) receptor modulator indicated for the treatment of moderately to severely active ulcerative colitis (UC) in adults. It exerts its therapeutic effect by reve...
What Is the Therapeutic Efficacy of Etrasimod?
Etrasimod is a sphingosine 1-phosphate (S1P) receptor modulator. It was approved for marketing by the U.S. FDA in 2023 for the treatment of moderate to severe active ulcerative colitis (UC) in adults....
Etrasimod: Precautions and Monitoring for Medication Use
Etrasimod is a sphingosine 1-phosphate (S1P) receptor modulator indicated for the treatment of moderate to severe active ulcerative colitis (UC) in adults.Etrasimod: Precautions and Monitoring for Med...
Precautions for Administration of ExtraSuperTadarise
ExtraSuperTadarise is a combined preparation, whose main ingredients are Tadalafil and Dapoxetine. It is used for the treatment of male erectile dysfunction (ED) and premature ejaculation (PE).Precaut...
What Is the Therapeutic Efficacy of ExtraSuperTadarise?
ExtraSuperTadarise is a combined preparation whose main ingredients include Tadalafil and Dapoxetine. It is used for the treatment of male erectile dysfunction (ED) and premature ejaculation (PE).What...
What are the side effects of ExtraSuperTadarise?
ExtraSuperTadarise is a combined preparation, whose main ingredients include Tadalafil and Dapoxetine. It is used for the treatment of male Erectile Dysfunction (ED) and Premature Ejaculation (PE). Ta...
Indications for Cabotegravir
Cabotegravir is a human immunodeficiency virus type 1 (HIV-1) integrase strand transfer inhibitor (INSTI) developed by ViiV Healthcare. It was first approved in the United States in 2021. As a signifi...
Related Articles
Dosage and Administration, Recommended Dosage of Capmatinib (Tabrecta)
Capmatinib (Tabrecta) is a highly selective MET inhibitor, offering a precision treatment option for patients with metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutation...
What Are the Indications for Capmatinib (Tabrecta)?
Capmatinib (Tabrecta) is a targeted therapy medication that plays an important role in the treatment of non-small cell lung cancer associated with specific gene mutations. As a MET kinase inhibitor, i...
What Are the Purchase Channels for Capmatinib (Tabrecta)?
Capmatinib (Tabrecta) is a highly selective MET inhibitor that has demonstrated significant efficacy in patients with metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutat...
Adverse Reactions of Ivosidenib (Tibsovo)
Ivosidenib (Tibsovo) is an isocitrate dehydrogenase 1 (IDH1) inhibitor, primarily indicated for the treatment of patients with acute myeloid leukemia, myelodysplastic syndromes, and cholangiocarcinoma...
What Are the Precautions for Using Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is a targeted therapy medication primarily indicated for the treatment of patients with malignant hematologic diseases harboring specific gene mutations.What Are the Precautions f...
Dosage and Administration, Recommended Dosage of Ivosidenib (Tibsovo)
Ivosidenib (Tibsovo) is a targeted isocitrate dehydrogenase 1 (IDH1) inhibitor that demonstrates significant value in the treatment of malignant tumors with specific gene mutations.Dosage and Administ...
What Are the Indications for Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is an oral isocitrate dehydrogenase-1 (IDH1) inhibitor indicated for patients with various malignant tumors harboring specific IDH1 gene mutations. By inhibiting the activity of m...
What Are the Purchase Channels for Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is an important targeted therapy drug against IDH1 mutations, demonstrating significant efficacy in diseases such as acute myeloid leukemia and cholangiocarcinoma. For patients in...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved